// . // Industries // Health And Life Sciences

What We Do

Our innovative thinking and strategic advice helps clients in the payer, provider, digital health, and life sciences sectors realize their most ambitious organizational and operational visions by bridging the gap between their business today and their vision for the future.

At Oliver Wyman, we are focused on creating positive change in healthcare, but we know we can’t do it all ourselves. Together, with today's leading healthcare experts and innovators, we’ve built a community to share and shape ideas that will transform healthcare. We work to ensure industry transformation through generating meaningful client impact, delivering strategic insights, and creating a healthcare system that meets the needs of communities and companies.

On November 1, 2021, the Huron life sciences strategy consulting team joined Oliver Wyman, allowing us to bring our relentless pursuit of a better way to pharmaceutical, biotechnology, and medical device companies. Our new colleagues bring the expertise needed to help life sciences companies tackle their most pressing strategic questions, including increasingly complex commercialization and access-related issues.

Client Impact

Our mission is to generate meaningful collaboration between cross-industry experts in order to nurture and inspire continued growth around the industry.

Insights

Oliver Wyman Health, our digital publication, is a virtual community of innovators showcasing ongoing strategic thinking about transforming care, engaging consumers, driving innovation, and maximizing value.

What We Think

Designing For 2035

Dive into the future of healthcare with industry leaders. Discover innovative strategies for designing a healthcare system for the next decade

The Impact Of Climate Change On Human Health

This new study projects as many as 14.5 million additional deaths and $12.5 trillion in economic losses by 2050

Life sciences Dealmaking Poised To Rebound In 2024

Investors should be encouraged by the increased need for new revenue streams and heightened demand for inorganic growth strategies among biopharma companies

Europe's Innovation Dilemma

Europe’s pharmaceutical industry risks falling behind the rest of the world without increased investment in innovation

How Pharma Can Achieve Net Zero Goals

Pharmaceutical companies are making bold pledges to reduce their carbon footprints. Getting there means overcoming some significant hurdles

The Case For Partnering With Your Competitors

From a potential recession to growing cost pressures, insurers face a host of uncertainties this year. One way to ease the pain is to take a cue from other industries and partner with competitors.

Cell and Gene Therapy Challenge

How to treat a million patients

A Personalized Model For Primary Care

Primary care must evolve to better meet patient needs and improve the patient experience.

Closing The Gender Health Gap

Pharma’s opportunity to move the needle on closing the gender health gap.

Solutions

Affordability And Quality Impact

There is immense pressure across the entire healthcare landscape to provide higher quality care, improve the patient experience, lower costs, and reduce clinician burnout. Our Affordability and Quality Impact practice has deep expertise across lines of business to help organizations identify cost drivers, find efficiencies, improve quality of care, and more.